NCT04423575

Brief Summary

This study first presents the organizational path and the health interventions included in the care episode for outpatient bariatric surgery, as compared to the health interventions usually performed in the care episode for bariatric surgery (including a conventional hospitalization with at least one-night inpatient). Then, the study aims to estimate and to compare the costs of bariatric surgery inpatient care episode to the costs of outpatient care episode, and also to evaluate the postoperative medical consequences.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 5, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
Same day until next milestone

Study Start

First participant enrolled

June 9, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 23, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 23, 2021

Completed
Last Updated

March 29, 2022

Status Verified

March 1, 2022

Enrollment Period

9 months

First QC Date

June 5, 2020

Last Update Submit

March 28, 2022

Conditions

Keywords

Severe ObesityOutpatient SurgeryBariatric SurgeryRoux-en-Y Gastric BypassSleeve Gastrectomy

Outcome Measures

Primary Outcomes (1)

  • Mean cost evaluation of health care pathway

    Mean costs related to the described health care pathway (outpatients vs inpatients) will be assessed by micro-costing methodology

    from the pre-operative appointment with the bariatric surgeon to the one-month post-operative appointment

Secondary Outcomes (6)

  • Mean hospital length of stay

    from surgery to one month postoperatively

  • Quality of life evaluation: EQ-5D (EuroQoL-5 Dimensions) scale

    at day 0, day 7 and day 30 postoperatively

  • Complication rate

    from surgery to one month postoperatively

  • Ambulatory failure rate

    from surgery to one month postoperatively

  • Readmission rate

    from surgery to one month postoperatively

  • +1 more secondary outcomes

Study Arms (2)

Outpatients

EXPERIMENTAL

Health care pathway: patient education, communication to liberal nurses, first-position surgical planning, bariatric surgery (bypass or sleeve) as outpatient procedure, follow-up by home nurse twice-a-day, standardized communication to surgeons, management of possible complications

Other: Outpatient health care pathway

Inpatients

NO INTERVENTION

Standard care pathway with bariatric surgery (bypass or sleeve) as inpatient procedure (at least one night in the hospital)

Interventions

A surgical procedure performed as an outpatient procedure means that the patient leaves the hospital before 8pm the same day. The surgery is identical but the standard care pathway is reinforced to insure a safe return to home.

Outpatients

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patient between the age of 18 and 60
  • Patient with a BMI of more than 35 with comorbidities or BMI of more than 40
  • Speaking and understanding French
  • Access to a phone
  • Access to a suitable healthcare facility near his residence
  • Appropriate post-operative residence
  • Moderate and/or controlled comorbidities
  • Patient able to understand research objectives and risks and to give informed consent
  • Patient not living alone
  • affiliated to the French health insurance system

You may not qualify if:

  • patient unable to provide informed consent
  • Previous bariatric surgery
  • Previous laparotomy
  • BMI of more than 50
  • Insulin-dependent diabetes
  • Uncorrected preoperative anaemia
  • Anticoagulation that cannot be interrupted
  • Ischemic heart disease
  • Untreated obstructive sleep apnea syndrome (OSA)
  • dialysis
  • Liver cirrhosis
  • Subject under guardianship, curatorship, safeguarding/protection of justice
  • Pregnancy
  • Breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Strasbourg, Department of Digestive and Endocrine Surgery

Strasbourg, France

Location

Related Publications (4)

  • Cobourn C, Mumford D, Chapman MA, Wells L. Laparoscopic gastric banding is safe in outpatient surgical centers. Obes Surg. 2010 Apr;20(4):415-22. doi: 10.1007/s11695-009-0065-7.

    PMID: 20077029BACKGROUND
  • McCarty TM, Arnold DT, Lamont JP, Fisher TL, Kuhn JA. Optimizing outcomes in bariatric surgery: outpatient laparoscopic gastric bypass. Ann Surg. 2005 Oct;242(4):494-8; discussion 498-501. doi: 10.1097/01.sla.0000183354.66073.4c.

    PMID: 16192809BACKGROUND
  • Ignat M, Vix M, Imad I, D'Urso A, Perretta S, Marescaux J, Mutter D. Randomized trial of Roux-en-Y gastric bypass versus sleeve gastrectomy in achieving excess weight loss. Br J Surg. 2017 Feb;104(3):248-256. doi: 10.1002/bjs.10400. Epub 2016 Nov 30.

    PMID: 27901287BACKGROUND
  • Ignat M, Ansiaux J, Osailan S, D'Urso A, Morainvillers-Sigwalt L, Vix M, Mutter D. A Cost Analysis of Healthcare Episodes Including Day-Case Bariatric Surgery (Roux-en-Y Gastric Bypass and Sleeve Gastrectomy) Versus Inpatient Surgery. Obes Surg. 2022 Aug;32(8):2504-2511. doi: 10.1007/s11695-022-06144-3. Epub 2022 Jun 10.

Related Links

MeSH Terms

Conditions

Obesity, Morbid

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mihaela IGNAT, MD, PhD

    Service de Chirurgie Digestive et Endocrinienne, NHC, Strasbourg

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2020

First Posted

June 9, 2020

Study Start

June 9, 2020

Primary Completion

February 23, 2021

Study Completion

February 23, 2021

Last Updated

March 29, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations